Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer: An Open-label, Multi-center, Prospective and Randomised Study

NCT02395640 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT02395640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02395640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer: An Open-label, Multi-center, Prospective and Randomised Study
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2015
Completion date
February 23, 2021
Enrollment
438 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer